General - Endochoice
Payments companies reported to CMS as associated with General - Endochoice. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with General - Endochoice, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with General - Endochoice
These are the largest totals companies reported as associated with General - Endochoice. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Rabia Latour | New York, NY | $2,886.37 | |
| Mihir Wagh | Aurora, CO | Gastroenterology (Internal Medicine) | $2,255.55 |
| Abubaker Abdalla | Rochester, MN | Hospitalist | $2,047.20 |
| Justin Forde | Gainesville, FL | Gastroenterology (Internal Medicine) | $2,025.00 |
| Dennis Yang | Orlando, FL | Gastroenterology (Internal Medicine) | $1,932.41 |
| Alireza Sedarat | Santa Monica, CA | Gastroenterology (Internal Medicine) | $1,916.64 |
| Joo Hwang | Stanford, CA | Gastroenterology (Internal Medicine) | $1,905.70 |
| Bradley Needleman | Columbus, OH | Surgery | $1,901.05 |
| Brandon Vanderwel | Shoreline, WA | Surgery | $1,832.76 |
| Christopher Northup | Charlottesville, VA | Surgery | $1,820.11 |
Prescribed General - Endochoice?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.